A high TROP2 gene expression, as determined by a combined immunohistochemical score of 9–12 points, was detected in approximately one quarter of the CRC samples analyzed and represents an independent negative prognostic factor. The gene discussed is TACSTD2; the disease is colorectal carcinoma.